Case Study

Reducing Cost within Advanced Therapy Clinical Trials

Source: Thermo Fisher Scientific

By Simon Ellison, Senior Manager, Advanced Therapy


The challenge for advanced therapy companies is that they need to develop a supply chain that delivers their therapy, at scale, without adding significantly to the cost of goods sold (COGS). In this case study, we’ll demonstrate how a company saw 55% cost savings across its distribution system, and increased visibility of its supply chain through meaningful data through partnering with Fisher BioServices and Fisher Clinical Services.